• Je něco špatně v tomto záznamu ?

Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer

S. Selvi, CM. Real, M. Gentiluomo, K. Balounova, K. Vokacova, A. Cumova, B. Mohlenikova-Duchonova, C. Rizzato, E. Halasova, L. Vodickova, B. Smolkova, K. Hemminki, D. Campa, P. Vodicka

. 2025 ; 113 (-) : 59-73. [pub] 20250515

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015129

Pancreatic cancer (PC) is becoming one of the most serious health problems at present, but its causes and risk factors are still unclear. One of the drivers in pancreatic carcinogenesis is altered genomic (DNA) integrity with subsequent genomic instability in cancer cells. The latter comprises a) DNA damage response and DNA repair mechanisms, b) DNA replication and mitosis, c) epigenetic regulation, and d) telomere maintenance. In our review we addressed the above aspects in relation to the most abundant and severe form of PC, pancreatic ductal adenocarcinoma (PDAC). In summary, the interactions between the DNA damage response, telomere homeostasis and mitotic regulation are not comprehensively understood at present, including the epigenetic factors entering the trait of genomic stability maintenance. In addition, the complexity of telomere homeostasis in relation to PDAC risk, prognosis and prediction also warrants further investigations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015129
003      
CZ-PrNML
005      
20250731090756.0
007      
ta
008      
250708e20250515enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.semcancer.2025.05.005 $2 doi
035    __
$a (PubMed)40378535
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Selvi, Saba $u Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, Prague 4 14200, Czech Republic; Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague 12800, Czech Republic
245    10
$a Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer / $c S. Selvi, CM. Real, M. Gentiluomo, K. Balounova, K. Vokacova, A. Cumova, B. Mohlenikova-Duchonova, C. Rizzato, E. Halasova, L. Vodickova, B. Smolkova, K. Hemminki, D. Campa, P. Vodicka
520    9_
$a Pancreatic cancer (PC) is becoming one of the most serious health problems at present, but its causes and risk factors are still unclear. One of the drivers in pancreatic carcinogenesis is altered genomic (DNA) integrity with subsequent genomic instability in cancer cells. The latter comprises a) DNA damage response and DNA repair mechanisms, b) DNA replication and mitosis, c) epigenetic regulation, and d) telomere maintenance. In our review we addressed the above aspects in relation to the most abundant and severe form of PC, pancreatic ductal adenocarcinoma (PDAC). In summary, the interactions between the DNA damage response, telomere homeostasis and mitotic regulation are not comprehensively understood at present, including the epigenetic factors entering the trait of genomic stability maintenance. In addition, the complexity of telomere homeostasis in relation to PDAC risk, prognosis and prediction also warrants further investigations.
650    _2
$a lidé $7 D006801
650    12
$a nestabilita genomu $7 D042822
650    12
$a nádory slinivky břišní $x genetika $x patologie $7 D010190
650    12
$a poškození DNA $7 D004249
650    12
$a homeostáza telomer $x genetika $7 D059505
650    _2
$a zvířata $7 D000818
650    _2
$a epigeneze genetická $7 D044127
650    _2
$a oprava DNA $7 D004260
650    12
$a duktální karcinom slinivky břišní $x genetika $x patologie $7 D021441
650    12
$a telomery $x genetika $7 D016615
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Real, Carmen Macías $u Cancer Predisposition and Biomarkers Group, Instituto de Investigacion Sanitaria de Santiago, Santiago de Compostela, Spain
700    1_
$a Gentiluomo, Manuel $u Department of Biology, University of Pisa, Pisa 56123, Italy
700    1_
$a Balounova, Katerina $u Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, Prague 4 14200, Czech Republic; Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Vokacova, Klara $u Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, Prague 4 14200, Czech Republic
700    1_
$a Cumova, Andrea $u Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava 84505, Slovakia
700    1_
$a Mohlenikova-Duchonova, Beatrice $u Department of Oncology, Olomouc University Hospital, Zdravotniku 248/7, Olomouc 77900, Czech Republic
700    1_
$a Rizzato, Cosmeri $u Department of Biology, University of Pisa, Pisa 56123, Italy
700    1_
$a Halasova, Erika $u Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, Martin 03601, Slovakia
700    1_
$a Vodickova, Ludmila $u Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, Martin 03601, Slovakia; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, Pilsen 32300, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, Prague 12800, Czech Republic
700    1_
$a Smolkova, Bozena $u Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava 84505, Slovakia
700    1_
$a Hemminki, Kari $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, Pilsen 32300, Czech Republic; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, FRG 69120, Germany
700    1_
$a Campa, Daniele $u Department of Biology, University of Pisa, Pisa 56123, Italy
700    1_
$a Vodicka, Pavel $u Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4, Martin 03601, Slovakia; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, Pilsen 32300, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, Prague 12800, Czech Republic. Electronic address: Pavel.Vodicka@lfp.cuni.cz
773    0_
$w MED00004316 $t Seminars in cancer biology $x 1096-3650 $g Roč. 113 (20250515), s. 59-73
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40378535 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090751 $b ABA008
999    __
$a ok $b bmc $g 2366163 $s 1252254
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 113 $c - $d 59-73 $e 20250515 $i 1096-3650 $m Seminars in cancer biology $n Semin Cancer Biol $x MED00004316
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...